MULTI-DIMENSIONAL RESISTANCE PHENOTYPE ALLOWS QUIESCENT LEUKEMIC STEM CELLS RESIDING AFTER TYROSINE KINASE INHIBITOR TREATMENT TO ESCAPE FROM IMMUNOLOGICAL INTERVENTIONS WITH ALLOREACTIVE T CELLS AND NK CELLS